Financial

Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors

BOSTON, March 23, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical stage biotechnology company developing novel…

1 year ago

Nanox.AI Expands Footprint Through New Global Partnership with Ferrum Health

Partnership with Ferrum Health offers unprecedented data security and an integrated AI platform to streamline health systems’ adoption of AI…

1 year ago

Gain Therapeutics to Participate in Virtual Fireside Chat On Computational Biology in Drug Discovery with Key Opinion Leaders

Panel, moderated by Hartaj Singh of Oppenheimer & Co., will be held on Wednesday, March 29, 2023 at 12:00 pm…

1 year ago

Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development

Collaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial ExecutionMORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos…

1 year ago

DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product

Former Reliq Health Technologies Chief Innovation Officer and veteran product leader brings over a decade of experience building and commercializing…

1 year ago

Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Achieved clinical validation of PRISM platform in 2022 – demonstrated ability to potently and durably engage RNA targets and translate…

1 year ago

Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Phase 1/2 clinical trial evaluating MRT-2359 for treatment of MYC-driven solid tumors ongoingDisclosure of initial data from Phase 1 arm…

1 year ago

MediGO Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023

The Baltimore-based digital healthcare supply chain technology company joins the ranks of OpenAI, Disney, Tiffany & Co., and moreBALTIMORE, March…

1 year ago

Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner

Comprehensive, multi-faceted IR program to focus on raising awareness of Predictive Oncology and its portfolio of unique, proprietary assets capable…

1 year ago